Developing a gene therapy for fetal disease: an interview with Anna David

Anna David (University College London, UK) discusses her research into the development of new treatments for fetal growth restriction using maternal gene therapy.

Go to the profile of RegMedNet
Jan 03, 2020
0
0

Filmed at this year's American Association of Pharmaceutical Scientists’ (AAPS) workshop on Opportunities and Challenges in Translating Cell and Gene Therapy Products (4–5 September; London, UK), we spoke to Anna David (University College London, UK) to look behind her lecture.

In the interview, she discusses the challenges of administering a fetal gene therapy, her experiences working with the UK regulators and more.

Find out more in these top picks from the Editor:


Go to the profile of RegMedNet

RegMedNet

eCommunity, Future Science Group

RegMedNet is a networking site where users can share their knowledge and insights. This profile will share some content and updates from the RegMedNet team, including webinars, news and journal articles.

No comments yet.